Request Discount
Infinium anniversary bonus, get Enterprise wide license report at the price of single user license till Q3 ends

Anatomic Pathology Testing Market (Component - Instruments, Consumables, and Services; Application - Disease Diagnosis, Drug Discovery & Development, and Other Applications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : December, 2020

  • Rep Id : HC0272

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on anatomic pathology testing market provides in-depth analysis of segments and sub-segments in the global as well as regional anatomic pathology testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional anatomic pathology testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global anatomic pathology testing market. According to the report, the global anatomic pathology testing market is projected to grow at a CAGR of 5.61% over the forecast period of 2020-2026.


Anatomic Pathology Testing Market

 

Market Insight

Anatomic pathology is a branch of science or medicine that predominantly involves a microscopic, biochemical, and molecular examination of organs and tissues to find out the efficiency of diseases. The main objective of anatomic pathology is to identify aberrations in order to manage diagnosis and treatment. It helps to detect numerous types of tumors and cancer. It is also sometimes useful to assess liver and kidney diseases efficiently. Anatomic pathology testing is a super-specialty test. To accomplish this type of test, a person should have a qualified certification from a recognized body, for instance, the American Board of Pathology or the American Osteopathic Board of Pathology. Like clinical pathology reports, anatomic pathology reports also comprise important elements such as name, number, sample type, and source. Numerous anatomic pathology departments operate according to the particular need of a patient.

 

An increase in the clinical usage of biomarkers allows pathologists to determine disease pathogenesis at a molecular level and guides in clinical decision-making, thereby enlightening patient outcomes. Rising reliance on biomarkers-based pathology tests and processes to explore common malignancy and tumorigenesis is boosting the anatomic pathology testing market. Furthermore, high usage of advanced pathology equipment, for example, staining systems, gross imaging, and digital microscopes is poised to expand anatomic pathological practices to a major extent. Moreover, digital imaging solutions provide specificity and accuracy-related benefits over conventional techniques, which in turn, propel the service uptake rate in the overall market. However, a lack of skilled professionals may hinder the market growth in the near future. On the other hand, an increasing number of clinical trials pertaining to cancer drugs provides lucrative opportunities for the market. 

 

Additionally, the current concern over the spread of coronavirus is also expected to have a negative impact on the anatomic pathology testing market. After COVID-19 was declared as an epidemic by the WHO, countries across the world adopted nationwide lockdowns to observe social distancing as a measure to curb the spread. This led to limitations, disruption, challenges, and changes in each sector of every sector. Likewise, the medical equipment & reagents sector was also impacted by the pandemic. Hence, the limited availability of medical care for conditions other than COVID-19 around the globe has impacted the number of medical equipment & reagent procedures conducted worldwide in a negative manner. Furthermore, the limited availability of healthcare staff across the globe is another foremost factor, which has a negative effect on the anatomic pathology testing industry.

 

Among the geographies, the North America region is expected to hold the largest share in the global anatomic pathology testing market. The industry is expected to offer huge opportunities for market growth on account of the presence of numerous healthcare companies. The increasing prevalence of chronic diseases, rapid upsurge in the geriatric population, and high acceptance of personalized medicine and digital laboratory propel the market in North America. Furthermore, the Asia Pacific region is expected to witness high growth in the anatomic pathology testing market during the forecast period. Increasing academic and government investment in diagnostic research and growing awareness about the usage of anatomic pathology tests among physicians in China, India, Japan, and East Asian countries is projected to provide positive opportunities for the market across the region.

 

Segment Covered

The report on the global anatomic pathology testing market covers segments such as component and application. On the basis of components, the sub-markets include instruments, consumables, and services. On the basis of application, the sub-markets include disease diagnosis, drug discovery & development, and other applications.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Sakura Finetechnical Co., Ltd., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Abbott Diagnostics, and Advanced Cell Diagnostics.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the anatomic pathology testing market. Moreover, the study highlights current market trends and provides forecasts from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount